NATCOPHARM.BO

NATCO Pharma Limited NATCOPHARM.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NATCOPHARM.BO CAPLIPOINT.NS GRANULES.BO GRANULES.NS JUBLPHARMA.BO JUBLPHARMA.NS APLLTD.BO APLLTD.NS CONCORDBIO.NS CONCORDBIO.BO
6M 0.55 % 5.45 % 17.68 % 17.83 % 20.28 % 19.69 % 9.41 % 9.69 % -12.59 % -12.50 %
YTD -40.40 % -19.97 % -5.43 % -5.29 % 1.77 % 1.52 % -11.26 % -11.15 % -30.35 % -30.32 %
1Y -39.19 % 5.94 % -4.39 % -4.23 % -6.94 % -7.37 % -18.47 % -18.30 % -23.45 % -23.75 %
3Y 40.97 % 172.53 % 62.75 % 62.61 % 241.52 % 239.31 % 71.29 % 71.56 % 58.75 % 59.00 %
5Y -9.73 % 279.65 % 44.36 % 44.36 % 58.47 % 57.88 % -5.26 % -5.05 % 58.75 % 59.00 %
10Y 59.78 % 643.24 % 270.51 % 270.53 % 182.66 % 181.72 % 28.81 % 28.94 % 58.75 % 59.00 %
From the beginning 29 671.43 % 5 516.20 % 18 437.70 % 5 329.94 % 244.19 % 1 976.72 % 1 926.80 % 1 943.86 % 58.75 % 59.00 %

Dividend

NATCO Pharma Limited

Caplin Point Laboratories Limited

Granules India Limited

Granules India Limited

Jubilant Pharmova Limited

Jubilant Pharmova Limited

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited

Concord Biotech Limited

Concord Biotech Limited